Author

Audrey Rousseau

Centre Hospitalier Universitaire d'AngersORCID 0000-0002-2496-9903Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:imaging· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. PerriniD· 1 shared Agustí AlentorniD· 1 shared Albert Pons‐EscodaiD· 1 shared Anna SchmittiD· 1 shared Anne ClavreuliD· 1 shared Béatrice ClemenceauiD· 1 shared Bertrand MathoniD· 1 shared Carole SoussainiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. PerrinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Morphologic intratumoral heterogeneity from routine whole-slide histopathology is prognostic for survival in primary central nervous system lymphoma: development in the LOC Network and international external validation

Lucas Rincón de la Rosa, Noemie Barillot, Isaias Hernández-Verdín, Roser Velasco, Bertrand Mathon, Sandrine Eimer, Jean Rodolphe Vignes, Audrey Rousseau, Jérôme Paillassa, Guido Ahle, Felix Lerintiu, Emmanuelle Uro‐Coste, Lucie Obéric, Émeline Tabouret, Romain Appay, , Agustí Alentorn

The paper develops and validates a prognostic model using morphologic intratumoral heterogeneity from histopathology slides to predict survival in primary central nervous system lymphoma.

bioRxiv · Sep 3, 2026 · PreprintBioinformatics

Functional diversity of Vγ9Vδ2 T cells overcomes glioblastoma state plasticity and antigen heterogeneity

Pierre Paris, Marine Devinat, Julianne Ceroni, Elodie Guiet, Jocelyn Ollier, Mélanie Laurent—Blond, Pauline Thomas, M. Gaudin, Noémie Joalland, A. Perrin, Clément Philippe Delannoy, Audrey Rousseau, Philippe Meneï, Emmanuel Scotet, François Paris, , Claire Pecqueur

This study shows that combining GD2/OAcGD2-specific CAR and unmodified Vγ9Vδ2 T cells can overcome glioblastoma heterogeneity by targeting both PN and MES tumor states.

bioRxiv · May 21, 2026 · PreprintCancer Biology